Shah Preetam 4
4 · Cidara Therapeutics, Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Sale
Common Stock
2023-03-13$1.53/sh−6,648$10,171→ 148,141 total
Footnotes (2)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP") on November 18, 2022.